Implications of SMAD4 Genetic Status in Recurrent Pancreatic Adenocarcinoma

被引：0
|
作者：
AlMasri, S. S. [1 ]
Zenati, M. [1 ]
Singhi, A. D. [1 ]
Lee, K. K. [1 ]
Bahary, N. [1 ]
Bartlett, D. [1 ]
Zureikat, A. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Surg Oncol, Pittsburgh, PA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
71
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] SMAD4 gene mutation and prognosis of pancreatic adenocarcinoma
    Derbel, Olfa
    de la Fouchardiere, Arnaud
    Peron, Julien
    Desseigne, Francoise
    Heudel, Pierre
    Guibert, Pierre
    Rivoire, Michel
    Meeus, Pierre
    Peyrat, Patrice
    Lemaistre, Anne-Isabelle
    De La Fouchardiere, Christelle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [2] The effect of SMAD4 expression on angiogenesis of pancreatic adenocarcinoma
    Schrödel, A.
    Jesnowski, R.
    Molema, I.
    Löhr, M.
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 : 74 - 74
  • [3] The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma
    Tascilar, M
    Skinner, HG
    Rosty, C
    Sohn, T
    Wilentz, RE
    Offerhaus, GJA
    Adsay, V
    Abrams, RA
    Cameron, JL
    Kern, SE
    Yeo, CJ
    Hruban, RH
    Goggins, M
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4115 - 4121
  • [4] SMAD4 Genetic Alterations Predict a Worse Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
    Singh, Puneet
    Srinivasan, Radhika
    Wig, Jai Dev
    PANCREAS, 2012, 41 (04) : 541 - 546
  • [5] SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma
    Dardare, Julie
    Witz, Andrea
    Merlin, Jean-Louis
    Gilson, Pauline
    Harle, Alexandre
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [6] DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma
    Biankin, AV
    Morey, AL
    Lee, CS
    Kench, JG
    Biankin, SA
    Hook, HC
    Head, DR
    Hugh, TB
    Sutherland, RL
    Henshall, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) : 4531 - 4542
  • [7] The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study
    Shin, Sang Hyun
    Kim, Hwa Jung
    Hwang, Dae Wook
    Lee, Jae Hoon
    Song, Ki Byung
    Jun, Eunsung
    Shim, In Kyong
    Hong, Seung-Mo
    Kim, Hyoung Jung
    Park, Kwang-Min
    Lee, Young-Joo
    Kim, Song Cheol
    ONCOTARGET, 2017, 8 (11) : 17945 - 17959
  • [8] Implications of SMAD4 Status in Pancreatic Carcinoma Treated With Radiation Therapy: A Multi-Institutional Analysis
    AlMasri, S. S.
    Zenati, M.
    Hammad, A.
    Singhi, A. D.
    Paniccia, A.
    Lee, K. K.
    Aldakkak, M.
    Evans, D. B.
    Tsai, S.
    Zureikat, A. H.
    Ellsworth, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S145 - S145
  • [9] SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
    Yu-Wen Chen
    Pi-Jung Hsiao
    Ching-Chieh Weng
    Kung-Kai Kuo
    Tzu-Lei Kuo
    Deng-Chyang Wu
    Wen-Chun Hung
    Kuang-Hung Cheng
    BMC Cancer, 14
  • [10] The role of Smad4/TGFB signaling in tumorigenesis of pancreatic ductal adenocarcinoma (PDAC).
    Yoo, Hannah
    Means, Anna
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 748 - 748
12345